Literature DB >> 7699949

[Urinary glycosaminoglycans in patients with incipient diabetic nephropathy].

I Ueta1, K Takamatsu, K Hashimoto.   

Abstract

To investigate the clinical significance of the urinary glycosaminoglycans excretion rate (GER) in patients with incipient diabetic nephropathy. GER was measured by the dye-binding method (Whiteman, 1972) in nocturnal urines of 30 normoalbuminuric (urinary albumin albumin excretion rate (AER) < 10 micrograms/min) and 10 microalbuminuric (10 < or = AER < 200 micrograms/min) diabetics without hypertension and 24 healthy control subjects. The mean GER in microalbuminuric diabetics was 56.5 +/- 15.0 micrograms/min and was significantly higher than that in the healthy controls (41.1 +/- 12.9 micrograms/min, p < 0.01). There was no significant difference in GER between normoalbuminuric diabetics and the healthy controls (50.2 +/- 36.3 micrograms/min, p < 0.1). GER correlated positively with HbA1c levels in the diabetics (r = 0.451, p < 0.01). In diabetics with good glycemic control (HbA1c, < 8.0%), GER positively correlated with urinary transferrin and albumin excretion rates (r = 0.593, 0.584, both p < 0.01), whereas it did not correlate significantly with N-acetyl-beta-D-glucosaminidase excretion rate (NAGER). In diabetics with poor glycemic control (HbA1c > or = 8.0%), GER correlated positively with NAGER (r = 0.626, p < 0.01), whereas it did not correlate significantly with urinary transferrin and AER. These results indicate that GER may be affected by glycemic control and is associated with the severity of the glomerular basement membrane lesion in well-controlled diabetics and with the severity of the tubulointerstitial lesion in poorly controlled diabetics. The measurement of GER is useful for determining the pathophysiological state in incipient diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699949

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  4 in total

1.  Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance.

Authors:  N Hiratsuka; K Shiba; K Nishida; S Iizima; M Kimura; S Kobayashi
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

2.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

Review 3.  Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Ligia Petrica; Romulus Timar; Silvia Velciov; Ioana Ionita; Adriana Kaycsa; Bogdan Timar
Journal:  J Diabetes Res       Date:  2016-06-16       Impact factor: 4.011

Review 4.  The role of novel biomarkers in predicting diabetic nephropathy: a review.

Authors:  Samuel N Uwaezuoke
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.